enzalutamide for biochemically recurrent prostate cancer | nejm
Published 9 months ago • 3.7K plays • Length 2:17Download video MP4
Download video MP3
Similar videos
-
2:11
prolonging progression-free survival in prostate cancer
-
13:24
enzalutamide approved for prostate cancer with biochemical recurrence: stephen freedland, md
-
1:44
monitoring, surgery, or radiotherapy for prostate cancer | nejm
-
7:21
nejm roundtable: screening for prostate cancer, part i
-
0:53
embark: subset analysis of enzalutamide versus leuprolide in prostate cancer
-
3:07
salv-enza: srt enzalutamide in high-risk psa-recurrent prostate cancer after radical prostatectomy
-
1:51
management of biochemical recurrence in prostate cancer
-
2:50
live from asco: apalutamide for castration-sensitive prostate cancer
-
12:43
maximizing results: 1st & 2nd generation hormone therapy from the outset? #markscholzmd #alexscholz
-
7:58
nejm roundtable: screening for prostate cancer, part ii
-
2:14
radium-223 and metastatic prostate cancer
-
1:00
most common side-effect of xtandi
-
1:33
the toparp-a trial
-
9:41
medical mystery solved – a treacherous course | nejm
-
7:17
medical mystery solved – a deficient diagnosis | nejm
-
0:53
dr. freedland on real-world utility of enzalutamide in prostate cancer
-
8:08
medical mystery solved – the road less traveled | nejm
-
2:14
salv-enza: srt plus enzalutamide for psa recurrent high-risk prostate cancer delays psa progression